Amerise Biosciences Reports Q2 FY27 Net Loss Amid Zero Operating Revenue
Amerise Biosciences Ltd 路 Financial Result 路 30 Oct 2026, 10:29 pm
Amerise Biosciences Reports Q2 FY27 Net Loss Amid Zero Operating Revenue Amerise Biosciences reported zero revenue from operations for the quarter ended 30th Sep'26, down from total income of Rs 6.75 lakh in Q2 FY26. Total expenses stood at Rs 5.76 lakh versus Rs 10.98 lakh YoY and Rs 8.14 lakh QoQ. Consequently, net loss widened YoY to Rs 5.76 lakh from Rs 4.23 lakh in Q2 FY26, though narrowing QoQ from Rs 8.14 lakh. EPS stood at negative Rs 0.01. For H1 FY27, net loss widened to Rs 13.91 lakh compared to Rs 5.04 lakh YoY.
Original exchange filing (PDF)
More announcements from Amerise Biosciences Ltd
- Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors .... 路 30 Oct 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Snehjeev Ventures Pvt Ltd 路 30 Oct 2026
- Amerise Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2026 ,inter alia, to consider and approve Pursuant to Regulation .... 路 30 Oct 2026
- PFA 路 10 Oct 2026
- PFA 路 24 Sept 2026
- PFA 路 24 Sept 2026
- Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Annual Report of the Company for the financial .... 路 01 Sept 2026
- PFA 路 01 Sept 2026
